Union Multicap Fund
The Scheme seeks to achieve long term capital appreciation by investing in equity and equity related instruments of large, mid and small cap companies.
Growthvine rating: 3/5 — ranked #9 of 35 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹16.50 (as of 2026-10-22) |
|---|
| AUM | ₹1,516 Cr |
|---|
| Expense ratio | 1.81% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harshad Patwardhan |
|---|
| Exit load | 1% for redemption within 15 days |
|---|
Performance & risk
| Sharpe ratio | 0.48 |
|---|
| Standard deviation | 15.96% |
|---|
| Max drawdown | −20.27% |
|---|
| Alpha | 4.29 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 100.7% of NIFTY500 Multicap 50:25:25's upside and 89.8% of its downside.
Market cap allocation
| Large cap | 33.5% |
|---|
| Mid cap | 32.3% |
|---|
| Small cap | 34.2% |
|---|
Concentration
| Top 5 holdings | 14.0% |
|---|
| Top 10 holdings | 23.6% |
|---|
| Total holdings | 75 |
|---|
| Index overlap | 29.8% |
|---|
| Active share | 70.2% |
|---|
Top holdings
- TREPS — 7.5%
- ICICI Bank Ltd. — 4.2%
- HDFC Bank Ltd. — 3.0%
- Larsen & Toubro Limited — 2.4%
- Karur Vysya Bank Ltd. — 2.3%
- One 97 Communications Limited — 2.1%
- Sun Pharmaceutical Industries Ltd. — 2.1%
- S.J.S. Enterprises Limited — 2.0%
- Dixon Technologies (India) Limited — 2.0%
- Sai Life Sciences Limited — 1.9%
Top sectors
- Banking & Financial — 19.7%
- Automobile — 10.8%
- Pharma & Biotech — 8.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 1.6% | Q1 (Top) | #8 of 34 |
| 2025 | 2.7% | Q3 | #18 of 31 |
| 2024 | 22.4% | Q3 | #14 of 24 |
| 2023 | 31.9% | Q2 | #9 of 17 |